EP1261331A4 - Method and compositions for treating fibrotic diseases - Google Patents

Method and compositions for treating fibrotic diseases

Info

Publication number
EP1261331A4
EP1261331A4 EP01910707A EP01910707A EP1261331A4 EP 1261331 A4 EP1261331 A4 EP 1261331A4 EP 01910707 A EP01910707 A EP 01910707A EP 01910707 A EP01910707 A EP 01910707A EP 1261331 A4 EP1261331 A4 EP 1261331A4
Authority
EP
European Patent Office
Prior art keywords
compositions
fibrotic diseases
treating fibrotic
treating
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01910707A
Other languages
German (de)
French (fr)
Other versions
EP1261331A1 (en
Inventor
Steve I Rennard
Tadashi Kohyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska Medical Center (UNMC)
Original Assignee
University of Nebraska Medical Center (UNMC)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska Medical Center (UNMC) filed Critical University of Nebraska Medical Center (UNMC)
Publication of EP1261331A1 publication Critical patent/EP1261331A1/en
Publication of EP1261331A4 publication Critical patent/EP1261331A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP01910707A 2000-02-16 2001-02-15 Method and compositions for treating fibrotic diseases Withdrawn EP1261331A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18287600P 2000-02-16 2000-02-16
US182876P 2000-02-16
US22762900P 2000-08-24 2000-08-24
US227629P 2000-08-24
PCT/US2001/004797 WO2001060358A1 (en) 2000-02-16 2001-02-15 Method and compositions for treating fibrotic diseases

Publications (2)

Publication Number Publication Date
EP1261331A1 EP1261331A1 (en) 2002-12-04
EP1261331A4 true EP1261331A4 (en) 2005-01-05

Family

ID=26878513

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01910707A Withdrawn EP1261331A4 (en) 2000-02-16 2001-02-15 Method and compositions for treating fibrotic diseases

Country Status (4)

Country Link
EP (1) EP1261331A4 (en)
JP (1) JP2004502643A (en)
AU (1) AU2001238288A1 (en)
WO (1) WO2001060358A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EP2020243B1 (en) * 2002-05-28 2018-08-15 AstraZeneca AB Topically applicable pharmaceutical preparation
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CN101969949B (en) * 2008-03-14 2013-12-25 大塚制药株式会社 MMP-2 and/or MMP-9 inhibitor
CA3034956A1 (en) * 2016-08-26 2018-03-01 Takeda Gmbh Treatment of nonalcoholic fatty liver disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301943A (en) * 1992-04-02 1994-08-31 Smithkline Beecham Corp COMPOUNDS.

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO0160358A1 *

Also Published As

Publication number Publication date
JP2004502643A (en) 2004-01-29
EP1261331A1 (en) 2002-12-04
AU2001238288A1 (en) 2001-08-27
WO2001060358A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
EP1353676A4 (en) Method for treating fibrotic diseases or other indications
GB0014969D0 (en) Novel method of treatment
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
AU8657601A (en) Composition and method for treatment of hypertriglyceridemia
GB0110288D0 (en) Composition and treatment method
EP1438062A4 (en) Methods and compositions for treating dermal lesions
AU2002232919A1 (en) Method for treating fibrotic diseases or other indications
IL144517A0 (en) Compositions and methods for treating cataracts
EP1351647A4 (en) Compositions and methods for treating hyperpigmentation
EP1404339A4 (en) Method for treating fibrotic diseases or other indications vi
EP1461047A4 (en) Compositions and methods for animal treatment
AU2002235692A1 (en) Methods and compositions for preventing and treating neutrophil-mediated diseases
HUP0203152A3 (en) Method and compositions for treating pulmonary diseases
HUP0300689A3 (en) Method and compositions for treating an inflammatory disease
EP1261331A4 (en) Method and compositions for treating fibrotic diseases
EP1349548A4 (en) Methods and compositions for treating periodontal disease
AU6970101A (en) Method for treatment and prevention of mastitis
HK1046853A1 (en) Method and compositions for treating hepatocellular cancer
GB0008921D0 (en) Method of treatment
GB0026838D0 (en) Treatment method
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
EP1303281A4 (en) Methods of treatment
AU2002353915A1 (en) Methods and compositions for treating rotavirus-mediated disease
GB0002762D0 (en) Method of treatment
GB0026742D0 (en) Novel method of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020806

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20041124

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050614